Back

Does prior MRA use limit eligibility for sacubitril valsartan in a heart failure clinic? Insights from real world experience and implications for ESC and NICE guidelines

26 May 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Chronic Heart Failure – Treatment Pharmacotherapy HFA Premium Access Heart Failure 2018

About the speaker

Photo
Doctor Libor Myslivecek

Bristol Heart Institute, Bristol (United Kingdom of Great Britain & Northern Ireland)

61 More presentations in this session

Presentation thumbnail
Real-world patterns of loop diuretics dose adjustment and association with outcomes in outpatients with chronic heart failure: observations from the ESC Heart Failure Long-Term Registry
Doctor C. Kapelios (Athens, GR)
Abstract Slides
Presentation thumbnail
Acute kidney failure and hyperkalaemia in patients with chronic hearth failure treated with aldosterone antagonists- a risk-benefit network meta-analysis
Presentation thumbnail
Intermittent administration of levosimendan ambulatory in patients with advanced chronic heart failure: experience in our center.
Presentation thumbnail
Sildenafil for chronic heart failure : a meta-analysis
Mrs C. Ariano (Naples, IT)
Abstract
Presentation thumbnail
The dilemma of recurrent hyperkalaemia and use of renin-angiotensin-aldosterone system inhibitors in heart failure with reduced ejection fraction: a European multi-national targeted chart review
Professor P. Rossignol (Monaco, MC)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 2 - Chronic Heart Failure – Treatment

The Event

Event poster

Heart Failure 2018

26 May - 29 May 2018
You may be interested in
thumbnail
Congress Presentation
Breaking the barriers in guideline-directed medical therapy implementation in heart failure - discussion
thumbnail
Congress Presentation
The role of ICD therapy in heart failure in 2024. What is the holistic approach to treat heart failure?
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources